- 全部删除
- 您的购物车当前为空
RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.
RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 41,650 | 10-14周 | |
50 mg | ¥ 54,200 | 10-14周 | |
100 mg | ¥ 69,800 | 10-14周 |
RK-582 相关产品
产品描述 | RK-582 is an orally efficacious spiroindolinone-based tankyrase inhibitor for the treatment of colon cancer. It exhibits a markedly improved robust tumor growth inhibition in a COLO-320DM mouse xenograft model when orally administered. |
分子量 | 510.6 |
分子式 | C27H35FN6O3 |
CAS No. | 2171388-28-4 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容